A multicenter comparison of quantification methods for antisense oligonucleotideinduced DMD exon 51 skipping in Duchenne muscular dystrophy cell cultures - Sorbonne Université
Article Dans Une Revue PLoS ONE Année : 2018

A multicenter comparison of quantification methods for antisense oligonucleotideinduced DMD exon 51 skipping in Duchenne muscular dystrophy cell cultures

Ruurd C Verheul
  • Fonction : Auteur
Nicole A Datson
  • Fonction : Auteur
Pietro Spitali
  • Fonction : Auteur
  • PersonId : 1105152

Résumé

Background Duchenne muscular dystrophy is a lethal disease caused by lack of dystrophin. Skipping of exons adjacent to out-of-frame deletions has proven to restore dystrophin expression in Duchenne patients. Exon 51 has been the most studied target in both preclinical and clinical settings and the availability of standardized procedures to quantify exon skipping would be advantageous for the evaluation of preclinical and clinical data.
Fichier principal
Vignette du fichier
pone.0204485.pdf (2.94 Mo) Télécharger le fichier
Origine Publication financée par une institution

Dates et versions

hal-03285360 , version 1 (13-07-2021)

Identifiants

Citer

Monika Hiller, Maria Sofia Falzarano, Iker Garcia-Jimenez, Valentina Sardone, Ruurd C Verheul, et al.. A multicenter comparison of quantification methods for antisense oligonucleotideinduced DMD exon 51 skipping in Duchenne muscular dystrophy cell cultures. PLoS ONE, 2018, 13 (10), pp.e0204485. ⟨10.1371/journal.pone.0204485⟩. ⟨hal-03285360⟩
101 Consultations
45 Téléchargements

Altmetric

Partager

More